The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

Aortic valve stenosis' is an often-overlooked condition and a growing health concern in ageing societies such as Thailand. With an increasing elderly population and a rise in age-related valve ...

BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...

Results from the EARLY TAVR trial — the first randomized, controlled FDA pivotal study designed to determine the best ...

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic ...

Real-world low-risk transcatheter aortic valve replacement (TAVR ... diagram and pivotal clinical trial eligibility or ineligibility. AS indicates aortic stenosis; AV, atrioventricular; BMI, body mass ...

med.ulaval.ca To be aware of the prevalence, pathophysiology and outcomes of mixed aortic valve disease (MAVD), which refers to combined aortic stenosis and aortic ... Edwards Lifesciences and ...

Researchers found that at five years, patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke.

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...

Sammy Elmariah, MD, MPH, and David Playford, MD, PhD discuss the ways technology and AI can be used to assist in better treatment and diagnosis of severe aortic stenosis.